Publications by authors named "A Mohandas"
Importance: Employer-sponsored benefit programs aim to increase access to behavioral health care, which may help contain health care costs. However, research has either focused solely on clinical outcomes or demonstrated reductions in medical claims without accounting for the costs of behavioral health services, leaving the financial return on investment unknown.
Objective: To determine whether a clinically effective employer-sponsored behavioral health benefit is associated with net medical cost savings.
Therapeutic Potential of Nutraceuticals against Drug-Induced Liver Injury.
Semin Liver Dis
November 2024
Article Synopsis
- Drug-induced liver injury (DILI) remains a significant challenge in healthcare, prompting the search for new treatments to protect liver function.
- This review explores the potential of nutraceuticals, such as silymarin, curcumin, and N-acetylcysteine, in reducing DILI through their effects on molecular mechanisms like oxidative stress and inflammation.
- The findings suggest that these nutraceuticals can effectively activate key cellular processes, including autophagy and the unfolded protein response, making them promising options for managing DILI.
In India, the prevalence of secondhand smoke (SHS) exposure is 29.5% in general and 11.2% at home.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to analyze how negative social and behavioral factors (SBDH) affect health care usage among heart failure patients at a safety-net community hospital.
- Out of 4,594 heart failure patients analyzed, 21% faced at least one adverse social or behavioral determinant, with a notable demographic skew towards younger Black males on Medicaid.
- Those with adverse SBDH experienced higher rates of hospitalizations and emergency department visits, indicating that these factors are linked to increased healthcare usage and serve as independent predictors for hospital readmissions.